Thus, MAP enables classify sporadic CRC, characterized by MLH1 promoter hypermethylation or MLH1 loss, whereas Lynch syndrome, a familiar syndrome, due to germline mutations of MMR or EPCAM gene1, may not be reflected. The gene discussed is EPCAM; the disease is colorectal carcinoma.